Palvella Therapeutics, Inc. Government Assistance Operating Income
Palvella Therapeutics, Inc. (PVLA) had Government Assistance Operating Income of $600.00 thousand as of 2025-10-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GovernmentAssistanceOperatingIncome · last filed 2026-03-31
- 2025-10-31: Government Assistance Operating Income $600.00K.
- 2025-05-31: Government Assistance Operating Income $500.00K.
| Period end | Government Assistance Operating Income |
|---|---|
| 2025-10-31 | $600.00K 10-K · filed 2026-03-31 |
| 2025-05-31 | $500.00K 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |